Table 4 Nanotechnology designs of co-delivery targeting drugs
From: Nanotechnology approaches to addressing HER2-positive breast cancer
Delivery system | HER2 targeting | Co-delivery | References |
|---|---|---|---|
Lipid-based nanoparticle | Trastuzumab | Rapamycin and quantum dots | Priyambada Parhi (2015) |
pH-sensitive double-emulsion nanocapsule | Trastuzumab | Magnetic nanoparticles/doxorubicin and paclitaxel | Chiang et al. (2014) |
Liposomal carrier | Targets immune response to breast cancer | Doxorubicin and indoximod | Lu et al. (2018) |